title: Guidance for development of chemopreventive agents.
authors.affiliation: Chemoprevention Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland 20892, USA.
authors.forename: G J
authors.initials: GJ
authors.lastname: Kelloff
authors.forename: J R
authors.initials: JR
authors.lastname: Johnson
authors.forename: J A
authors.initials: JA
authors.lastname: Crowell
authors.forename: C W
authors.initials: CW
authors.lastname: Boone
authors.forename: J J
authors.initials: JJ
authors.lastname: DeGeorge
authors.forename: V E
authors.initials: VE
authors.lastname: Steele
authors.forename: M U
authors.initials: MU
authors.lastname: Mehta
authors.forename: J W
authors.initials: JW
authors.lastname: Temeck
authors.forename: W J
authors.initials: WJ
authors.lastname: Schmidt
authors.forename: G
authors.initials: G
authors.lastname: Burke
mesh_terms: D000818:Animals; D016588:Anticarcinogenic Agents / Q000493:pharmacokinetics; D002986:Clinical Trials as Topic / Q000592:standards; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004341:Drug Evaluation / Q000331:legislation & jurisprudence / Q000592:standards; D004353:Drug Evaluation, Preclinical; D017408:Guidelines as Topic; D006801:Humans; D051379:Mice; D011817:Rabbits; D051381:Rats; D018675:Toxicity Tests / Q000592:standards
chemical_list: D016588:Anticarcinogenic Agents